Bcl-2 and the regulation of programmed cell death

Journal of Cell Biology

Volumn 124, Issue 1-2, 1994, Pages 1-6

  Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 3; NEUROTROPIC AGENT; PROTEIN P53;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; B CELL LEUKEMIA; B CELL LYMPHOMA; CELL DEATH; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; GENE ASSIGNMENT; GENE EXPRESSION REGULATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SHORT SURVEY;

EID: 0028040019     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.124.1.1     Document Type: Short Survey

References (70)

1. Allsopp, T. E., S. Wyatt, H. F. Paterson, and A. M. Davies. 1993. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:295-307.
2. Alnemri, E. S., N. M. Robertson, T. F. Fernandes, C. M. Croce, and G. Litwack. 1992. Overexpressed full-length human Bcl-2 extends survival of baculovirus-infected SF9 insect cells. Proc. Natl. Acad. Sci. USA. 89:7295-7299.
3. Asken, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 6:1915-1922.
4. Aster, J. C., Y. Kobayashi, M. Shiota, S. Mori, and J. Sklar. 1992. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am. J. Pathol. 141:291-299.
5. Bafy, G., T. Miyashita, J. R. Williamson, and J. C. Reed. 1993. Apoptosis induced by withdrawal of Interleukin-3 [IL-3] from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268:6511-6519.
6. Bissonnette, R. P., F. Exheverri, A. Mahboubi, and D. R. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (Lond.). 359:552-554.
7. Boise, L. H., M. Gonzåalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson, bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1-20.
8. Campos, L., J.-P. Roualult, O. Sabido, P. Oriol, N. Roubi, C. Vasselon, E. Archimbaud, J.-P. Magaud, and D. Guyotat. 1993. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 18:3091-3096.
9. Cazals-Hatem, D., D. Louie, S. Tanaka, and J. C. Reed. 1992. Molecular cloning and DNA sequence analysis of cDNA encoding chicken homolog of the Bcl-2 oncoprotein. Biochim. Biophys. Acta. 1132:109-113.
10. Chen-Levy, S., and M. L. Cleary. 1990. Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J. Biol. Chem. 265:4929-4933.
11. Clarke, A. R., C. A. Purdie, D. J. Harison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dpeendent and independent pathways. Nature (Lond.). 362:849-852.
12. Cleary, M. L., S. D. Smith, and J. Sklar. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:19-28.
13. Collins, M. K. L., J. Marvel, P. Malde, and A. Lopez-Rivas. 1992. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med. 176:1043-1051.
14. Dowd, D. R., p. N. MacDonald, B. S. Komm, M. R. Haussler, and R. L. Miesfeld. 1992. Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol. Endocrinol. 6:1843-1848.
15. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.
16. Fanidi, A., E. A. Harrington, and G. I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (Lond.). 359:554-556.
17. Fernandez, M. J., and J. R. Bischoff. 1993. Bcl-2 associates with the ras-related protein R-ras p23. Nature (Lond.). 366:274-275.
18. Finke, J., R. Fritzen, P. Ternes, P. Trivedi, K. J. Bross, W. Lange, R. Mertelsmann, and G. Dölken. 1992. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood. 80:459-469.
19. Fisher, T. C., A. E. Milner, C. D. Gregory, A. L. Jackman, G. W. Aherne, J. A. Hartley, C. Dive, and J. A. Hickman. 1993. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res. 53:3321-3326.
20. Garcia, I., I. Martinou, Y. Tsujimoto, and J.-C. Martinou. 1992. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science (Wash. DC). 258:302-304.
21. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1107.
22. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA. In press.
23. Hennet, T., G. Bertoni, C. Richter, and E. Peterhans. 1993. Expression of Bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53:1456-1460.
24. Hockenbery, D., G. Nunez, C. Milliman, R. D. Schreiber, and S. J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.). 348:334-336.
25. Hockenbery, D. M., M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer. 1991. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA. 88:6961-6965.
26. Hockebery, D., Z. Oltvai, X.-M. Yin, C. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxident pathway apoptosis. Cell. 75:241-251.
27. Jacobson, M. D., J. F. Burne, M. P. King, T. Miyashita, J. C. Reed, and M. C. Raff. 1993. Apoptosis and Bcl-2 protein in cells without mitochondrial DNA. Nature (Lond.). 361:365-368.
28. Kane, D. J., T. A. Sarafin, S. Auton, H. Hahn, F. B. Gralla, J. C. Valentine, T. Ord, and D. E. Bredesen. 1993. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science (Wash. DC). 262: 1274-1276.
29. Kitada, S., T. Miyashita, S. Tanaka, and J. C. Reed. 1993. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res. & Develop. 3:157-169.
30. Kozopas, K. M., T. Yang, H. L. Buchan, P. Zhou, and R. W. Craig. 1993. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proc. Natl. Acad. Sci. USA. 90:3516-3520.
31. Krajewski, S., S. Tanaka, S. Takayama, M. J. Schibler, W. Fenton, and J. C. Reed. 1993. Investigations of the subcellular distribution of the BCL-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:4701-4714.
32. Lam, M., G. Dubyak, and C. W. Distelhorst. 1993. Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells. Mol. Endocrinol. 7:686-693.
33. LeBrun, D. P., R. A. Warnke, and M. L. Cleary. 1993. Expression of bcl-2 in fetal tissues suggests a role in morphologenesis. Am. J. Pathol. 142: 743-753.
34. Levine, B., Q. Huang, J. T. Isaacs, J. C. Reed, D. E. Griffin, and J. M. Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (Lond.). 361:739-742.
35. H rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene. 6:2271-2276.
36. Lin, E. Y., A. Orlofsky, M. Bergar, and M. B. Prystowsky. 1993. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151:1979-1988.
37. Lotem, J., and L. Sachs. 1989. Induction of dependence on hematopoietic proteins for viability and receptor upregulation in differentiating myeloid leukemic cells. Blood. 74:579.
38. Lotem, J., and L. Sachs. 1993. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth & Differ. 4:41-47.
39. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.). 362:847-849.
40. Lu, Q-L., R. Poulsom, L. Wong, and A. M. Hanby. 1993. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol. 169:431-437.
41. Mah, S. P., L. T. Zhong, Y. Liu, A. Roghani, R. H. Edwards, and D. E. Bredesen. 1993. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60:1183-1186.
42. McDonnell, T. J., N. Deane, F. M. Platt, G. Numez, V. Jaeger, J. P. McKearn, and S. J. Korsmeyer. 1989. bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell. 57:79-88.
43. McDonnell, T. J., P. Troncoso, S. M. Brisbay, C. Logothetis, L. W. K. Chung, J.-T. Hsieh, S.-M. Tu, and M. L. Campbell. 1992. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52:6940-6944.
44. Miyashita, T., and J. C. Reed. 1992. Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52:5407-5411.
45. Miyashita, T., and J. C. Reed. 1993. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood. 81:151-157.
46. Monaghan, P., D. Robertson, A. S. Amos, M. J. S. Dyer, D. Y. Mason, and M. F. Greaves. 1992. Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem. 40:1819-1825.
47. Neilan, J., Z. Lu, C. Afonso, G. Kutish, M. Sussman, and D. L. Rock. 1993. An African Swine Fever virus gene with similarity to the bcl-2 proto-oncogene and the Epstein Barr virus gene BHRF-1. J. Virol. 67:4341-4394.
48. Nowell, P. C., and C. M. Croce. 1987. Cytogenetics of neoplasia. In Development and Recognition of the Transformed Cell. M. I. Greene and T. Hamaoka, editors. Plenum Publishing Corporation. New York.
49. Oberhammer, F. A., M. Pavelka, S. Sharma, R. Tiefenbacher, A. F. Purchio, W. Bursch, and R. Schulte-Hermann. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA. 89:5408-5412.
50. Oltari, Z., C. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell. 74:609-619.
51. Reed, J., S. Haldar, M. Cuddy, C. Croce, and D. Makover. 1990a. BCL2-mediated tumorigenicity in a T-lymphoid cell line: Synergy with C-MYC and inhibition by Bcl-2 antisense. Proc. Natl. Acad. Sci. USA. 87:3660-3664.
52. Reed, J., C. Stein, S. Haldar, C. Subasinghe, C. Croce, S. Yum, and J. Cohen 1990b. Antisense-mediated inhibition of BCL2 proto-oncogene expression and leukemic cell growth: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res. 50:6565.
53. Sachs, L., and Lotem, J. 1993. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood. 82:15-21.
54. Sato, T., S. Irie, S. Krajewski, and J. C. Reed. 1994. Cloning and sequencing of cDNA encoding rat Bcl-2 protein. Gene (Amst.). In press.
55. Sentman, C. L., J. R. Shutter, D. Hockenbery, O. Kanagawa, and S. J. Korsmeyer. 1991. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:879.
56. Shi, Y., J. M. Glynn, L. J. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. 1992. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Wash. DC). 257:212-214.
57. Siegel, R., M. Katsumata, T. Miyashita, D. Louie, M. Greene, and J. C. Reed. 1992. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc. Natl. Acad. Sci. USA. 89:7003.
58. Strasser, A., A. W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889.
59. Takayama, S., D. L. Cazals-Hatem, S. Kitada, S. Tanaka, T. Miyashita, L. R. Hovey, D. Huen, A. Rickinson, P. Veerapandian, S. Krajewski, K. Saito, and J. C. Reed. 1993. Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoprotein: structure-function implications. DNA and Cell Biology. In press.
60. Tanaka, S., K. Saito, and J. C. Reed. 1993. Structure-function analysis of the apoptosis-suppressing Bcl-2 oncoprotein: substitution of a heterologous transmembrane domain restores function to truncated Bcl-2 proteins. J. Biol. Chem. 268:10920-10926.
61. Tsujimoto, Y., and C. M. Croce. 1986. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA. 83:5214-5218.
62. Tsujimoto, Y., J. Cossman, E. Jaffe, and C. Croce. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Wash. DC). 228:1440-1443.
63. Tushinski, R. J., I. T. Oliver, L. J. Guilbert, P. W. Tynan, J. R. Warner, and E. R. Stanley. 1982. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that differentiated cells specifically destroy Cell. 28:71.
64. Vaux, D., S. Cory, and J. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.). 335:440-442.
65. Walton, W. I., D. Whysong, P. M. O'Connor, D. Hockenbery, S. J. Korsmeyer, and K. W. Kohn. 1993. Constitutive expression of human Bcl-2 modulates mitogen mustard and camptothecin induced apoptosis. Cancer Res. 53:1853-1861.
66. Wang, Y., L. Szekely, I. Okan, G. Klein, and K. G. Wiman. 1993. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene. 8:3427-3431.
67. Williams, G. T., C. A. Smith, E. Spooncer, T. M. Dexter, and D. R. Taylor. 1990. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature (Lond.). 343:76-79.
68. Yunis, J. J., M. G. Mayer, M. A. Arensen, D. P. Aeppli, M. M. Oken, and G. Frizzera. 1989. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphomas. N. Engl. J. Med. 320:1047-1054.
69. Zhan, Q., F. Carrier, and A. J. Fornace Jr. 1993. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell Biol. 13:4242-4250.
70. Zhong, L.-T., T. Sarafian, D. J. Kane, A. C. Charles, S. P. Mah, R. H. Edwards, and D. E. Bredesen. 1993. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad Sci. USA. 90:4533-4537.